Intact Investment Management Inc. Pfizer Inc Transaction History

Intact Investment Management Inc.

$2.79 Billion
Q3 2024

A detailed history of Intact Investment Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Intact Investment Management Inc. holds 437,500 shares of PFE stock, worth $11 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

437,500

Previous 423,200 3.38%

Holding current value

$11 Million

Previous $11.8 Million 6.93%

% of portfolio

0.45%

Previous 0.49%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$27.7 - $31.39 $396,110 - $448,877	14,300 Added 3.38%	437,500 $12.7 Million
Q2 2024 Jul 30, 2024	BUY	$25.26 - $29.6 $964,932 - $1.13 Million	38,200 Added 9.92%	423,200 $11.8 Million
Q1 2024 May 03, 2024	SELL	$25.89 - $29.73 $1.39 Million - $1.6 Million	-53,800 Reduced 12.26%	385,000 $10.7 Million
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $2.71 Million - $3.52 Million	103,600 Added 30.91%	438,800 $12.6 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $824,713 - $964,007	-25,700 Reduced 7.12%	335,200 $11.1 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $484,007 - $559,986	-13,400 Reduced 3.58%	360,900 $13.2 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $1.68 Million - $2.18 Million	42,600 Added 12.84%	374,300 $15.3 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $2.23 Million - $2.92 Million	-53,500 Reduced 13.89%	331,700 $17 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.87 Million - $2.29 Million	42,800 Added 12.5%	385,200 $16.9 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $744,480 - $882,720	-16,000 Reduced 4.46%	342,400 $18 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $2.08 Million - $2.57 Million	45,400 Added 14.5%	358,400 $18.6 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $173,544 - $257,250	-4,200 Reduced 1.32%	313,000 $18.5 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $1.62 Million - $2.08 Million	-41,200 Reduced 11.5%	317,200 $13.6 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $129,275 - $146,448	-3,600 Reduced 0.99%	358,400 $14 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $870,740 - $982,020	-26,000 Reduced 6.7%	362,000 $13.1 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $2.38 Million - $2.79 Million	-75,000 Reduced 16.2%	388,000 $14.2 Million
Q2 2020 Jul 29, 2020	BUY	$30.12 - $36.54 $1.06 Million - $1.28 Million	35,100 Added 8.2%	463,000 $15.1 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $1.71 Million - $2.44 Million	63,200 Added 17.33%	427,900 $14 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $813,124 - $922,792	24,700 Added 7.26%	364,700 $14.3 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $1.2 Million - $1.56 Million	37,000 Added 12.21%	340,000 $12.2 Million
Q2 2019 Jul 30, 2019	BUY	$36.98 - $41.52 $122,033 - $137,016	3,300 Added 1.1%	303,000 $13.1 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $142,500 - $156,560	3,800 Added 1.28%	299,700 $12.7 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $3.89 Million - $4.72 Million	-112,800 Reduced 27.6%	295,900 $13 Million
Q2 2018 Jul 25, 2018	SELL	$32.98 - $35.16 $471,613 - $502,787	-14,300 Reduced 3.38%	408,700 $14.8 Million
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $4.4 Million - $5.11 Million	-137,900 Reduced 24.59%	423,000 $15 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $212,864 - $225,856	-6,400 Reduced 1.13%	560,900 $20.3 Million
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $17.6 Million - $19.4 Million	567,300	567,300 $20.2 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intact Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Intact Investment Management Inc. with notifications on news.

Account

Intact Investment Management Inc. Pfizer Inc Transaction History